Related Experiment Videos
Case report: verapamil-induced subacute cutaneous lupus erythematosus
Boaz Kurtis1, Matthew J Larson, Mai P Hoang
1Department of Medicine, St. Luke's-Roosevelt Hospital Center, New York, NY, USA.
Journal of Drugs in Dermatology : JDD
|July 12, 2005
Abstract:
Calcium-channel blockers (CCB), including verapamil, nifedipine, and diltiazem, are one of the most widely prescribed class of drugs in the treatment of cardiovascular disease. In the last several years, CCBs have been linked with a distinct cutaneous subset in the lupus spectrum, subacute cutaneous lupus erythematosus (SCLE), and we describe a case induced by verapamil.